---
document_datetime: 2023-09-21 19:54:41
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/recarbrio-epar-all-authorised-presentations_en.pdf
document_name: recarbrio-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.845346
conversion_datetime: 2025-12-22 09:13:06.679146
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EMA Number       | (Invented) name   | Strength                 | Pharmaceutical Form              | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|--------------------------|----------------------------------|---------------------------|-----------------------|-------------|
| EU/1/19/1420/001 | Recarbrio         | 500 mg / 500 mg / 250 mg | Powder for solution for infusion | Intravenous use           | Vial (glass)          | 25 vials    |